2D Is Better: Engineering Polydopamine into Cationic Nanosheets to Enhance Anti‐Inflammatory Capability
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Lulu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, P. R. China. Hauptthemen laut MEDLINE: Polymers, Indoles, Anti-Inflammatory Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, University Synergy Innovation Program of Anhui Province, Key Laboratory of Antiinflammatory and Immune Medicine.
Abstract (Originalsprache)
Polydopamine nanomaterials have emerged as one of the most popular organic materials for the management of oxidative stress‐mediated inflammatory diseases. However, their current anti‐inflammatory ability is still unsatisfactory because of limited phenolic hydroxyl groups, and oxidation reaction‐medicated reactive oxygen and nitrogen species (RONS) scavenging. Herein, via fusing dimension engineering and surface charge engineering, 2D cationic polydopamine nanosheets (PDA NSs) capable of scavenging multiple danger signals to enhance anti‐inflammatory capability are reported. Compared with conventional spherical polydopamine nanoparticles, 2D PDA NSs exhibit three‐ to fourfold enhancement in RONS scavenging capability, which should be attributed to high specific surface area and abundant phenol groups of 2D ultrathin structure. To further enhance the anti‐inflammatory ability, polylysine molecules are absorbed on the surface of PDA NSs to endow the scavenging capability of cell‐free DNA (cfDNA), another typical inflammatory factor to exacerbate the pathogenesis of inflammation. Molecular mechanisms reveal that cationic PDA NSs can concurrently activate Keap1‐Nrf2 and block TLR9 signaling pathway, achieving synergistical inflammation inhibition. As a proof of concept, cationic PDA NSs with RONS and cfDNA dual‐scavenging capability effectively alleviate the inflammatory bowel disease in both delayed and prophylactic models, much better than the clinical drug 5‐aminosalicylic acid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, P. R. China.
- Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei, 230031, P. R. China.
- The Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, 230032, P. R. China.
- Department of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, P. R. China.
ORCID-Profile: Zhaohua Miao
Förderung
- National Natural Science Foundation of China
- University Synergy Innovation Program of Anhui Province
- Key Laboratory of Antiinflammatory and Immune Medicine
- Ministry of Education, P.R. China
Zitieren
APA
Liu, L., Lu, C., Tao, Z., Zha, Z., Wang, H., & Miao, Z. (2024). 2D Is Better: Engineering Polydopamine into Cationic Nanosheets to Enhance Anti‐Inflammatory Capability. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400048
Vancouver
Liu L, Lu C, Tao Z, Zha Z, Wang H, Miao Z. 2D Is Better: Engineering Polydopamine into Cationic Nanosheets to Enhance Anti‐Inflammatory Capability. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400048
BibTeX
@article{Liu2024,
author = {Liu, Lulu and Lu, Chenxin and Tao, Zhenchao and Zha, Zhengbao and Wang, Hua and Miao, Zhaohua},
title = {2D Is Better: Engineering Polydopamine into Cationic Nanosheets to Enhance Anti‐Inflammatory Capability},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400048}
}
EUVIMED